Cargando…
A Randomized Controlled Trial Evaluating Outcome Impact of Cilostazol in Patients with Coronary Artery Disease or at a High Risk of Cardiovascular Disease
Previous studies found that cilostazol has a favorable effect on glucose and lipid homeostasis, endothelial function, atherosclerosis, and vasculo-angiogenesis. However, it is poorly understood whether these effects can translate into better clinical outcomes. This study investigated the outcome eff...
Autores principales: | Lin, Jia-Ling, Tseng, Wei-Kung, Lee, Po-Tseng, Lee, Cheng-Han, Tseng, Shih-Ya, Chen, Po-Wei, Chang, Hsien-Yuan, Chao, Ting-Hsing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225272/ https://www.ncbi.nlm.nih.gov/pubmed/35743723 http://dx.doi.org/10.3390/jpm12060938 |
Ejemplares similares
-
Diverse Effects of Cilostazol on Proprotein Convertase Subtilisin/Kexin Type 9 between Obesity and Non-Obesity
por: Chen, Po-Wei, et al.
Publicado: (2022) -
Effect of cilostazol on plasma levels of proprotein convertase subtilisin/kexin type 9
por: Chen, I-Chih, et al.
Publicado: (2017) -
Effects of Cilostazol on Angiogenesis in Diabetes through Adiponectin/Adiponectin Receptors/Sirtuin1 Signaling Pathway
por: Tseng, Shih-Ya, et al.
Publicado: (2022) -
Impact of routine coronary catheterization in low extremity artery disease undergoing percutaneous transluminal angioplasty: study protocol for a multi-center randomized controlled trial
por: Chen, I-Chih, et al.
Publicado: (2016) -
Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9 Are Elevated in Patients With Peripheral Artery Disease and Associated With Metabolic Disorders and Dysfunction in Circulating Progenitor Cells
por: Chao, Ting‐Hsing, et al.
Publicado: (2016)